{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 457153102
| IUPAC_name = (''RS'')-5-(2-{[3-(''tert''-butylamino)-2-hydroxypropyl]sulfanyl}- 1,3-thiazol-4-yl)thiophene-2-carboxamide
| image = Arotinolol.svg
| width = 275

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|arotinolol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral ([[Tablet (pharmacy)|tablets]])

<!--Pharmacokinetic data-->
| bioavailability = 2 hours
| protein_bound =  
| metabolism =  
| elimination_half-life = 10 hours
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 41287-43-8
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 93298
| PubChem = 2239
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 394E3P3B99
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07465

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2152

<!--Chemical data-->
| chemical_formula =  
| C=15 | H=21 | N=3 | O=2 | S=3 
| molecular_weight = 371.54 g/mol
| smiles = CC(C)(C)NCC(CSC1=NC(=CS1)C2=CC=C(S2)C(=O)N)O
|  StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H21N3O2S3/c1-15(2,3)17-6-9(19)7-21-14-18-10(8-22-14)11-4-5-12(23-11)13(16)20/h4-5,8-9,17,19H,6-7H2,1-3H3,(H2,16,20)
|  StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BHIAIPWSVYSKJS-UHFFFAOYSA-N
}}

'''Arotinolol''' ([[International Nonproprietary Name|INN]], marketed under the tradename '''Almarl''') is a [[medication]] in the class of mixed alpha/[[beta blocker]]s.<ref name="pmid11478592">{{cite journal |author=Zhao |title=Arotinolol is a weak partial agonist on beta 3-adrenergic receptors in brown adipocytes |journal=[[Can J Physiol Pharmacol]] |volume=79 |issue=7 |pages=585–593 |date=July 2001 |pmid=11478592 |doi= 10.1139/cjpp-79-7-585|url=http://article.pubs.nrc-cnrc.gc.ca/ppv/RPViewDoc?issn=0008-4212&volume=79&issue=7&startPage=585|first = Jin|first2 = Valeria|last2 = Golozoubova|first3 = Barbara|last3 = Cannon|first4 = Jan|last4 = Nedergaard}}{{Closed access}}</ref> It also acts as a [[Beta-3 adrenergic receptor|β<sub>3</sub> receptor]] [[agonist]].<ref name="pmid1383578">{{cite journal|last1=Takahashi|first1=H|last2=Yoshida|first2=T|last3=Nishimura|first3=M|last4=Nakanishi|first4=T|last5=Kondo|first5=M|last6=Yoshimura|first6=M|title=Beta-3 Adrenergic Agonist, BRL-26830A, and Alpha/Beta Blocker, Arotinolol, Markedly Increase Regional Blood Flow in the Brown Adipose Tissue in Anesthetized Rats|journal=Japanese Circulation Journal|date=September 1992|volume=56|issue=9|pages=936–42|pmid=1383578|doi=10.1253/jcj.56.936}}<!--|accessdate=6 March 2016--></ref> A 1979 publication suggests arotinolol as having first been described in the scientific literature by [[Sumitomo Chemical]] as "β-adrenergic blocking, antiarrhythmic compound S-596".<ref>{{Cite journal|title = 新しいβ-受容体遮断薬，dl-2-(3'-t-Butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)-thiazole hydrochloride (S-596) の薬理作用|year = 1979|url = https://www.jstage.jst.go.jp/article/fpj1944/75/7/75_7_707/_article|first = Youichi|last = Hara|last2 = Sato|first2 = Etsuro|first3 = Akira|last3 = Miyagishi|first4 = Shunzi|last4 = Aono|first5 = Hiroshi|last5 = Nakatani|journal = Folia Pharmacologica Japonica|doi = 10.1254/fpj.75.707|issn = 1347-8397|pages = 707–720|language = Japanese|type = English abstract|trans_title = Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride (S-596), a new β-adrenergic blocking agent<!--provided by publisher-->}}{{Open access}}</ref>

==Uses==
It is used in the treatment of [[hypertension|high blood pressure]]<ref name="pmid11675958">{{cite journal |author=Wu |title=Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers |journal=Hypertension Research |volume=24 |issue=5 |pages=605–10 |date=September 2001 |pmid=11675958 |doi= 10.1291/hypres.24.605|url=https://www.jstage.jst.go.jp/article/hypres/24/5/24_5_605/_pdf |format=PDF|issn = 1348-4214|first = Haiying|last2 = Zhang|first2 = Yuqing|first3 = Jianfeng|last3 = Huang|last4 = Zhang|first4 = Yuhui|last5 = Liu|first5 = Guozhang|last6 = Sun|first6 = Ningling|last7 = Yu|first7 = Zhenqui|last8 = Zhou|first8 = Yanrong}}{{Open access}}</ref> and [[essential tremor]].<ref name="pmid12853233">{{cite journal |author=Lee |title=A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor |journal=Parkinsonism & Related Disorders |volume=9 |issue=6 |pages=341–347 |date=August 2003 |pmid=12853233 |doi= 10.1016/S1353-8020(03)00029-4|url=http://download.journals.elsevierhealth.com/pdfs/journals/1353-8020/PIIS1353802003000294.pdf|first = Kwang-Soo|first2 = Joong-Seok|last2 = Kim|first3 = Jae-Woo|last3 = Kim|first4 = Won-Yong|last4 = Lee|first5 = Beum-Seok|last5 = Jeon|first6 = Dongjae|last6 = Kim}}{{Closed access}}</ref><ref>{{cite web|title=Almarl (アルマール) Arotinolol HCl Tablets. Full Prescribing Information|url=https://ds-pharma.jp/product/almarl/pdf/almarl_tab_tenpu.pdf|publisher=Sumitomo Dainippon Pharma Co., Ltd.|accessdate=6 March 2016}}</ref>

Recommended dosage is 10–30&nbsp;mg per day.

==References==
{{reflist|2}}

==External links==
* {{ja icon}} [https://ds-pharma.jp/product/almarl/pdf/almarl_tab_tenpu.pdf Almarl Full Prescribing Information. Revised November 2009] Sumitomo Dainippon Pharma Co., Ltd.
* {{ja icon}} [http://www.ds-pharma.co.jp Official Sumitomo Dainippon Pharma Website]
* https://web.archive.org/web/20110722132720/http://sdic.sookmyung.ac.kr/drug_monograph/view.asp?id=92

{{Beta blockers}}
{{Adrenergics}}

[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Beta blockers]]
[[Category:Carboxamides]]
[[Category:Thiazoles]]
[[Category:Thioethers]]
[[Category:Thiophenes]]


{{antihypertensive-stub}}
{{amine-stub}}